drugset / Trial / NCT00084708

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

NCT00084708

Phase 1 Completed 53 enrolled Roswell Park Cancer Institute
NaSingle-groupTreatment

Summary

RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. Calcitriol may help tumor cells develop into normal cells. Dexamethasone may increase the effectiveness and decrease the side effects of gefitinib and calcitriol. PURPOSE: This phase I trial is studying the side effects and best dose of calcitriol when given together with gefitinib or when given together with gefitinib and dexamethasone in treating patients with advanced solid tumors.

Timeline

Start
2002-11
Primary completion
2006-10
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule Oral
Background Gefitinib Small molecule Oral